Venture Capital Archives - Page 12 of 108 - Boston Life Sciences Times

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

November 25, 2025

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

November 14, 2025

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

November 13, 2025

THIS WEEK'S STORIES

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

November 25, 2025

RapidAI Extends Deep Clinical AI Capabilities With Five New FDA Clearances

November 25, 2025

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

November 26, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

MindImmune Extends Series A to $30 Million to Advance Alzheimer’s Therapy and Names Isaac Stoner as CEO

Veolia to Acquire Clean Earth, Expanding U.S. Hazardous Waste Operations and Advancing Global Growth Strategy

Profluent Raises $106 Million to Scale Frontier AI Models for Programmable Biology

Synthio Labs Raises $5 Million to Build Voice AI Operating System for Life Sciences Engagement

AI Proteins Raises $41.5 Million Series A to Advance De Novo Miniprotein Medicines

Most Read

GE HealthCare Receives FDA Authorization for Deep-Learning Mammography Reconstruction Tool

Otsuka’s VOYXACT Wins FDA Accelerated Approval for IgA Nephropathy Proteinuria Reduction

Galux Reports AI Engine Produced High-Affinity Antibodies From Only 50 Designs

EdgeOne Medical Hires Industry Veteran Marty Shelton as Chief Operating Officer

EDITOR PICKS

Vyome Appoints Dr. Aditya Bardia as Senior Medical Advisor to Guide Development of MFW Program

Boston Life Sciences Times Announces 2025 Vanguard Award Winners

Mursla Bio Partners with Global Pharmaceutical Company to Advance Biomarker-Guided Precision Medicine in MASH

THIS WEEK'S STORIES

Inflammasome Therapeutics Completes Enrollment of Phase II Study for Dual Inflammasome Inhibitor K8 to Treat Geographic Atrophy

RapidAI Extends Deep Clinical AI Capabilities With Five New FDA Clearances

AstraZeneca’s IMFINZI Gets First U.S. Approval for Perioperative Use in Early Gastric and GEJ Cancers

POPULAR CATEGORY

ABOUT US

FOLLOW US